We are referring to recently inked deal of Sensimed with SEED from Japan. The duo longs to address and identify glaucoma issues at early stage.
Sensimed’s contact lens that goes by the name Triggerfish, measures the dimensional change of the eye for time duration of 24 hours. It then uploads this data into software via Bluetooth. The data recorded is used in diagnosing and treating of glaucoma.
Sensimed had received CE mark in Sep 2009 and FDA nod in March, 2016. Unexplored APAC waters have recently been touched by Sensimed through its deal with SEED.
Sensimed’s company page has a phrase which says:
“The Company is directly positioned at the convergence between devices, treatment and information”.
We think with each day Sensimed is justifying this claim with much more vigour, while its accomplishments go about acknowledging the same.